430 results on '"Nagata, Noriyo"'
Search Results
2. Author Correction: Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice
3. An outbreak of SARS-CoV-2 omicron variant and deaths of three lions in a zoo
4. Pathological and virological findings of type I interferon receptor knockout mice upon experimental infection with Heartland virus
5. Saturation time of exposure interval for cross-neutralization response to SARS-CoV-2: Implications for vaccine dose interval
6. Results from a preclinical study in rodents and a Phase 1/2, randomized, double-blind, placebo-controlled, parallel-group study of COVID-19 vaccine S-268019-a in Japanese adults
7. Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways
8. Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice
9. Isolation and characterization of Helicobacter suis from human stomach
10. Characterization of Keterah orthonairovirus and evaluation of therapeutic candidates against Keterah orthonairovirus infectious disease
11. Mice, myeloid cells, and dengue: a new model for unraveling vascular leakage mysteries
12. Mpox Neutralizing Antibody Response to LC16m8 Vaccine in Healthy Adults
13. Enhanced isolation of SARS-CoV-2 by TMPRSS2- expressing cells
14. Lethal severe fever with thrombocytopenia syndrome virus infection causes systemic germinal centre failure and massive T cell apoptosis in cats
15. 2141. Preclinical Evaluation of PA-001: A Novel, Potential Macrocyclic Peptide-Based Treatment for COVID-19 Which Binds to the S2 Subunit of SARS-CoV-2 Spike Protein
16. Dengue virus infection induces selective expansion of Vγ4 and Vγ6TCR γδ T cells in the small intestine and a cytokine storm driving vascular leakage in mice
17. High-throughput isolation of SARS-CoV-2 nucleocapsid antibodies for improved antigen detection
18. Characterization of novel monoclonal antibodies against the MERS-coronavirus spike protein and their application in species-independent antibody detection by competitive ELISA
19. Specific COVID-19 risk behaviors and the preventive effect of personal protective equipment among healthcare workers in Japan
20. Estimating serum cross-neutralizing responses to SARS-CoV-2 Omicron sub-lineages elicited by pre-Omicron or Omicron breakthrough infection with exposure interval compensation modeling
21. Severe Fever with Thrombocytopenia Syndrome Phlebovirus causes lethal viral hemorrhagic fever in cats
22. Protective effects of the Francisella tularensis ΔpdpC mutant against its virulent parental strain SCHU P9 in Cynomolgus macaques
23. Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters
24. Isolation and characterization of a novel Rhabdovirus from a wild boar (Sus scrofa) in Japan
25. Macrophage Depletion Reactivates Fecal Virus Shedding following Resolution of Acute Hepatitis A in Ifnar1 –/– Mice
26. Results from a preclinical study in rodents and a Phase 1/2, randomized, double-blind, placebo-controlled, parallel-group study of COVID-19 vaccine S-268019-a in Japanese adults
27. First isolation and characterization of pteropine orthoreoviruses in fruit bats in the Philippines
28. Interleukin-17A released from intestinal γδT cells induces cytokine storm in mice with severe dengue
29. Role of VP30 Phosphorylation in Ebola Virus Nucleocapsid Assembly and Transport
30. Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology
31. Impact of reinfection with SARS-CoV-2 Omicron variants in previously infected hamsters
32. The First Identification and Retrospective Study of Severe Fever With Thrombocytopenia Syndrome in Japan
33. Highly Attenuated Vaccinia Virus Dis as a Potential Sars Vaccine
34. Pathological and Virological Analyses of Severe Acute Respiratory Syndrome–Associated Coronavirus Infections in Experimantal Animals
35. Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys
36. Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variants
37. Transgenic mouse model for the study of enterovirus 71 neuropathogenesis
38. Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8+ T cell responses
39. Infection of Hantaan virus strain AA57 leading to pulmonary disease in laboratory mice
40. Prophylactic Vaccine Targeting TLR3 on Dendritic Cells Ameliorates Eosinophilic Pneumonia in a Mouse SARS-CoV Infection Model
41. A Transgenic Mouse Model of Poliomyelitis
42. Puumala virus infection in Syrian hamsters (Mesocricetus auratus) resembling hantavirus infection in natural rodent hosts
43. Identification and molecular characterization of a new nonsegmented double-stranded RNA virus isolated from Culex mosquitoes in Japan
44. A lethal mouse model for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection
45. A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable site
46. Establishment of a panel of in-house polyclonal antibodies for the diagnosis of enterovirus infections
47. Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workers
48. The Pathogenesis of 3 Neurotropic Flaviviruses in a Mouse Model Depends on the Route of Neuroinvasion After Viremia
49. Comparison of acellular pertussis-based combination vaccines by Japanese control tests for toxicities and laboratory models for local reaction
50. Susceptibility to flavivirus-specific antiviral response of Oas1b affects the neurovirulence of the Far-Eastern subtype of tick-borne encephalitis virus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.